KRAS and malignant colon neoplasm: Taken together, mutations in APC, TP53, KRAS and loss of chromosome 18q, i.e. genomic aberrations that are highly prevalent and well-known from the colon tumor progression model [22, 23], were associated with disease deterioration in this series of MSS colon cancers.